Harvard Bioscience (HBIO) Other Working Capital Changes (2018 - 2026)

Harvard Bioscience (HBIO) has reported Other Working Capital Changes for 11 consecutive years, with -$29000.0 the latest figure, recorded in Q3 2020.

• On a quarterly basis, Other Working Capital Changes rose 76.03% year-over-year to -$29000.0 in Q3 2020; TTM through Sep 2020 was $41000.0, a 104.54% increase from a year earlier, with the FY2019 full-year figure at -$305000.0, up 89.34% from the prior year.
• Other Working Capital Changes was -$29000.0 for Q3 2020 at Harvard Bioscience, down from $472000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.4 million in Q3 2022 and troughed at -$2.3 million in Q4 2023.
• A 5-year average of -$338833.3 and a median of -$271000.0 in 2025 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 2881.25% in 2018, down 7275.0% in 2018.
• Over 5 years, Other Working Capital Changes stood at -$216000.0 in 2016, then soared by 98.15% to -$4000.0 in 2017, then sank by 7275.0% to -$295000.0 in 2018, then soared by 202.71% to $303000.0 in 2019, then plunged by 109.57% to -$29000.0 in 2020.
• The last three Other Working Capital Changes figures came in at -$29000.0 (Q3 2020), $472000.0 (Q2 2020), and -$705000.0 (Q1 2020), per Business Quant data.